Decentralized Trial Technology Videos
-
Why Site Burden Goes Beyond eSource
6/12/2026
Beth Harper explains why the real problem is broader than eSource and why sponsors should integrate around the systems sites already use.
-
Ask Sites What Technology They Already Use
6/12/2026
Rosie Filling says sponsors should stop guessing and ask sites what tech they use so teams can design with sites, not just for them.
-
Why Standards Matter At Scale
6/12/2026
Joe Dustin shows why custom integrations do not scale and why standards are essential for efficiently connecting many sites.
-
Site Tech, Integration, And Reducing Burden
6/12/2026
Beth Harper, Rosie Filling, and Joe Dustin discuss site tech, integration, and how sponsors can reduce burden while improving flow.
-
Paying Sites To Reduce Burden
6/12/2026
Beth Harper and Rosie Filling discuss site burden, enrollment pressure, and why sponsors should help pay for technology and training.
-
Validation And Why Sponsors Say Yes
6/12/2026
Joe Dustin explains why validation documentation and sponsor benefit are key to getting approval for site-system integration.
-
Together, We Are On A Mission: Enabling Treatments To Reach Patients
4/22/2026
This AI-powered digital clinical trials platform enhances speed, scale, and patient access in clinical research, accelerating medicines for thousands of conditions without treatment or cure.
-
On-site ePRO Solutions For Flexible Data Collection Across Devices
3/17/2026
Optimize flexible electronic patient-reported outcomes that allow participants to switch between site-owned devices, personal hardware, and remote completion.
-
Designed To Help Sites Increase Clinical Trial Capacity
7/25/2025
IQVIA One Home for Sites is a platform that serves as a neutral aggregator, connector, and communicator of the key systems and tasks a clinical research site needs to perform across all the trials it is conducting.
-
Real-World DHT Adherence Insights And Good Practices
7/10/2025
While advances in sensors and device design are improving wearability, successful data collection still hinges on participant adherence. The session highlights why addressing this can’t be an afterthought.